EFFECT OF DEEP BREATHING EXERCISES ON COVID-19 PATIENTS
Study Details
Study Description
Brief Summary
Studies reveal that the Covid-19 virus can be transmitted in three ways: respiratory tract, direct contact and feces. The incubation period is estimated to be 5.2 [4.1-7.0] days for the 95% confidence interval and the virus transmission coefficient (R0) baseline growth number is 2.2 [1.4-3.9]. The main signs and symptoms described in the literature are; other atypical symptoms, particularly fever (98%), cough (76%), myalgia or fatigue (44%); sputum (28%), headache (8%), hemoptysis (5%), vomiting (5%), diarrhea (3%) and shortness of breath were detected. In addition to lymphopenia, which is detected in 63% of cases, pneumonia is also present. Widely regarded as the cornerstone of pulmonary rehabilitation, exercise training is the best way to improve muscle function in COPD and other chronic respiratory diseases. After 326 patients hospitalized in the pandemic clinical services of a public hospital were randomly divided into the experimental (n=168) and control groups (n=168), the effect of the experiment on the respiratory parameters of the experiment will be monitored without any intervention in the control group, while deep breathing and coughing exercises will be applied to the experimental group. The aim of this study is to determine the effect of deep breathing and coughing exercises on respiratory parameters in patients treated for pneumonia due to COVID-19 disease.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
A new virus called SARS-CoV-2 was detected on January 7, 2020, as a result of the investigations carried out in 27 pneumonia cases of unknown cause in December 2019 in Wuhan, China's Hubei province (Gonzalez-Gerez et al., 2020). The World Health Organization (WHO) announced on January 30, 2020 that it is facing a virus that threatens public health, and a pandemic was declared on March 11, 2020 (WHO, 2020).
Studies reveal that the virus can be transmitted in three ways: respiratory tract, direct contact and feces (Qun, 2020). The incubation period is 5.2 [4.1-7.0] days for the 95% confidence interval, and the basic reproduction number for R0 is 2.2 [1.4-3.9]. ] (Q. Li et al., 2020; Qun, 2020).
The main signs and symptoms described in the literature are; other atypical symptoms, particularly fever (98%), cough (76%), myalgia or fatigue (44%); dyspnea (55%), sputum (28%), headache (8%), hemoptysis (5%), vomiting (5%) and diarrhea (3%). In addition to lymphopenia, which was detected in 63% of cases, all patients had pneumonia. Complications include acute respiratory distress syndrome (29%), acute heart injury (12%), and secondary infections (10%) (Huang et al., 2020; Wang et al., 2020a). Other more striking symptoms such as chemosensory dysfunction have also been described (Yan et al., 2020). Most of the patients diagnosed with COVID-19 have at least one underlying chronic disease (such as hypertension, chronic obstructive pulmonary disease), and many of these patients have to be treated in intensive care units (ICU). (Huang et al., 2020; Wang et al., 2020a). It is estimated that 80% of patients will present with mild symptoms that can be followed up without hospitalization. It is predicted that the remaining 20% may need medical clinical care, of which 5% may need to be hospitalized in the intensive care unit (Guan et al., 2020). The mean time from onset of symptoms to recovery is 2 weeks in patients with mild symptoms, but 3-6 weeks in patients with severe or critical disease. (Gonzalez-Gerez et al., 2020).
The international consensus on managing patients with Covid-19-associated acute respiratory distress syndrome (ARDS) is that despite the increasing number of reports on respiratory system mechanics and ventilation management, more experimental studies are needed (Fan et al., 2020). It is thought that death cases due to Covid-19 are mostly caused by ARDS (Burki, 2020). The reported incidence of ARDS among all Covid-19 patients is 15.6-31%, but is higher than other organ damage rates (X. Li & Ma, 2020). With the recent increase in hospitalized Covid-19 patients, different management strategies have begun to be needed by healthcare professionals to save the lives of patients with ARDS (Daher et al., 2021; Gattinoni et al., 2020).
In the literature, research on the pathophysiology of Covid-19 is still limited. However, evidence based on laboratory findings and clinical pathological characteristics of Covid-19 patients suggests that secretion of large amounts of mucus in the airway interferes with the ventilation and alveolar formation process and interstitial changes are the mechanisms underlying the impairment of gas exchange. Studies have reported that the duration of ARDS development in Covid-19 patients is on average 8-12 days after the first symptoms appear (X. Li & Ma, 2020). Corticosteroid therapy and high-flow nasal oxygen therapy are frequently used in patients who develop ARDS. ARDS is shown as the most common cause of mortality in Covid-19 patients (Wang et al., 2020b; Zhao et al., 2021). Widely regarded as the cornerstone of pulmonary rehabilitation, exercise training is recognized as the best way to improve muscle function in COPD and other chronic respiratory diseases. It is indicated for patients with reduced exercise tolerance, exercise dyspnea or fatigue, impaired daily living activities, and chronic respiratory disease.(Felten-Barentsz et al., 2020) In line with these data, it is thought that specific deep breathing and coughing exercises may be beneficial to reduce reversible pulmonary changes such as secretions and interstitial fluid accumulation, maximize the area of the alveolar sacs, and accelerate the secretion clearance process.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: experimental group In addition to the routine care in the hospital, the patient will be given deep breathing and coughing exercises. |
Other: deep breathing and coughing exercises with triflo
patients will be given triflo. A video of the application of deep breathing and coughing exercises with triflo prepared by the researchers will be prepared. The video will be sent to the patients' phones. It will be ensured that the patients do the exercises every hour by watching the video and they will be followed.
|
No Intervention: Control group There will be no intervention other than routine nursing care practices in the hospital. |
Outcome Measures
Primary Outcome Measures
- THE EFFECT OF DEEP BREATHING AND CUTTING EXERCISE ON RESPIRATORY PARAMETERS IN PATIENTS WITH COVID-19 ASSOCIATED PNEUMONIA [between 1st and 10nd days]
The effect of breathing and coughing exercises with triflo on respiratory parameters in Covid-19 pneumonia
Secondary Outcome Measures
- blood values, hemodynamic parameters [between 1st and 10nd days]
The effect of deep breathing and coughing exercises with triflo on blood values and hemodynamic parameters in patients with covid-19 pneumonia
Eligibility Criteria
Criteria
Inclusion Criteria:
-
be over 18
-
be conscious
-
to know Turkish
-
Not having any sensory or perceptual disability
-
Being sick with Covid-19 pneumonia
-
Volunteer
Exclusion Criteria:
-
be under the age of 18
-
not being conscious
-
Not knowing Turkish
-
Presence of any sensory or perceptual disability
-
Not having covid-19 pneumonia
-
Receiving mechanical ventilation support
-
not volunteering
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Özge Uçar
- Bartin State Hospital
Investigators
- Study Director: Sevim ÇELİK, Prof., Bartin University Health Science Faculty
- Study Chair: Suna UZUN, Nurse, Bartin State Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2021-FEN-A-016